These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 6377067
1. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure. Malluche HH, Smith AJ, Abreo K, Faugere MC. N Engl J Med; 1984 Jul 19; 311(3):140-4. PubMed ID: 6377067 [Abstract] [Full Text] [Related]
2. Bone histologic response to deferoxamine in aluminum-related bone disease. Andress DL, Nebeker HG, Ott SM, Endres DB, Alfrey AC, Slatopolsky EA, Coburn JW, Sherrard DJ. Kidney Int; 1987 Jun 19; 31(6):1344-50. PubMed ID: 2441107 [Abstract] [Full Text] [Related]
3. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? Hodsman AB, Hood SA, Brown P, Cordy PE. J Lab Clin Med; 1985 Dec 19; 106(6):674-81. PubMed ID: 4067379 [Abstract] [Full Text] [Related]
4. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients. Nutr Rev; 1985 Apr 19; 43(4):103-5. PubMed ID: 3923410 [No Abstract] [Full Text] [Related]
11. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM. Arch Intern Med; 1986 Oct 19; 146(10):2063-4. PubMed ID: 3767553 [Abstract] [Full Text] [Related]
13. Early deposition of aluminum in bone in diabetic patients on hemodialysis. Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ. N Engl J Med; 1987 Feb 05; 316(6):292-6. PubMed ID: 3807961 [Abstract] [Full Text] [Related]
14. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis]. Wang G, Zhu P, Wang S. Zhonghua Nei Ke Za Zhi; 1996 Jan 05; 35(1):36-40. PubMed ID: 9275645 [Abstract] [Full Text] [Related]